Bone Biologics Corp Annual Operating Income (Loss) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Bone Biologics Corp quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2023.
  • Bone Biologics Corp Operating Income (Loss) for the quarter ending September 30, 2024 was -$951K, a 54.3% increase year-over-year.
  • Bone Biologics Corp Operating Income (Loss) for the twelve months ending September 30, 2024 was -$3.82M, a 60% increase year-over-year.
  • Bone Biologics Corp annual Operating Income (Loss) for 2023 was -$9.43M, a 157% decline from 2022.
  • Bone Biologics Corp annual Operating Income (Loss) for 2022 was -$3.67M, a 232% decline from 2021.
  • Bone Biologics Corp annual Operating Income (Loss) for 2021 was -$1.1M, a 33.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$9.43M -$5.76M -157% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-21
2022 -$3.67M -$2.56M -232% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-21
2021 -$1.1M -$278K -33.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$825K +$1.62M +66.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 -$2.45M +$343K +12.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-04-15
2018 -$2.79M -$164K -6.26% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
2017 -$2.63M +$17.8M +87.1% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
2016 -$20.4M -$8.42M -70.2% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 -$12M -$8.99M -298% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-30
2014 -$3.01M -$2.34M -348% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-28
2013 -$672K Jan 1, 2013 Dec 31, 2013 10-K 2015-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.